ArticleBlood2024

Zinzani PL, Thieblemont C, Melnichenko V, et al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170. Blood. 2023;142(2):141-145.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.